TickerFactsScreenerDevelopers

Organogenesis Holdings Inc. (ORGO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$4.87M2017: -$3.49M2018: -$60.63M2019: -$33.53M2020: $5.47M2021: $61.98M2022: $24.86M2023: $30.92M2024: $14.21M2025: -$10.31M-$10.31M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$10.31M-172.6%
2024$14.21M-54.0%
2023$30.92M+24.4%
2022$24.86M-59.9%
2021$61.98M+1033.9%
2020$5.47M+116.3%
2019-$33.53M+44.7%
2018-$60.63M-1635.9%
2017-$3.49M+28.3%
2016-$4.87M—